IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lanxess Posts Huge Hike in Profits; Raises Earnings Forecast; Scales Back Cost-Cutting Plans

3:47 AM MDT | August 6, 2010 | Natasha Alperowicz

Lanxess beat market expectations for the second quarter as a result of a strong performance in emerging markets, reporting Ebitda pre-exceptionals of €269 million ($354 million) compared to €112 million in the year-earlier period. Sales were up 48% at €1.83 billion and net profit soared to €131 million from €17 million in the second quarter of 2009. The company has raised its earnings forecast for 2010 and now expects Ebitda pre-exceptionals of "roughly €800 million," compared with forecasts made in May of €650 million...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa